Marc Goodman
Stock Analyst at Leerink Partners
(4.84)
# 398
Out of 4,377 analysts
842
Total ratings
54.8%
Success rate
17%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics | Maintained: Buy | n/a | $30.01 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $16.44 | +112.90% | 1 | May 27, 2026 | |
| ACIU AC Immune | Maintained: Buy | n/a | $2.25 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Maintained: Hold | n/a | $42.80 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $18.78 | +123.64% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $91.69 | -18.20% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $1.63 | +390.80% | 1 | Jan 11, 2026 | |
| BHVN Biohaven | Maintained: Buy | $50 → $15 | $10.80 | +38.89% | 26 | Dec 25, 2025 | |
| MPLT MapLight Therapeutics | Initiated Coverage: Buy | $30 | $28.01 | +7.10% | 1 | Nov 21, 2025 | |
| OVID Ovid Therapeutics | Initiated Coverage: Buy | $5 | $2.40 | +108.33% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $143.35 | -40.70% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $11.21 | +346.03% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $30 | $21.56 | +39.15% | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $195.34 | - | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 | $238.57 | -9.88% | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $51.73 | - | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $232.32 | - | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.67 | - | 42 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $13.32 | +50.15% | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $28.60 | +18.88% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $163.88 | - | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.44 | +350.45% | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $19.52 | +104.92% | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.63 | +513.50% | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $23.55 | -15.07% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $7.01 | +413.55% | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.95 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.0497 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $232.77 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $10.55 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $1.88 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $67.00 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $1.06 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.01 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $58.34 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $135.44 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.57 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $181.34 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $446.83 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $635.45 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $57.27 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $15.88 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $26.04 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $20 | $34.19 | n/a | 26 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $120.79 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $227.23 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $10.83 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $1,131.42 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $13.75 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 | $129.16 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $23.44 | n/a | 1 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $3.31 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $7.49 | n/a | 24 | Mar 21, 2016 |
Stoke Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $30.01
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $16.44
Upside: +112.90%
AC Immune
Apr 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.25
Upside: -
Alkermes
Mar 31, 2026
Maintained: Hold
Price Target: n/a
Current: $42.80
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $18.78
Upside: +123.64%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $91.69
Upside: -18.20%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.63
Upside: +390.80%
Biohaven
Dec 25, 2025
Maintained: Buy
Price Target: $50 → $15
Current: $10.80
Upside: +38.89%
MapLight Therapeutics
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $28.01
Upside: +7.10%
Ovid Therapeutics
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.40
Upside: +108.33%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $143.35
Upside: -40.70%
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $11.21
Upside: +346.03%
Oct 7, 2025
Maintained: Buy
Price Target: $32 → $30
Current: $21.56
Upside: +39.15%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $195.34
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $215
Current: $238.57
Upside: -9.88%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $51.73
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $232.32
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $6.67
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $10 → $20
Current: $13.32
Upside: +50.15%
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $28.60
Upside: +18.88%
Sep 23, 2025
Maintained: Buy
Price Target: n/a
Current: $163.88
Upside: -
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $4.44
Upside: +350.45%
Aug 13, 2025
Maintained: Buy
Price Target: $40
Current: $19.52
Upside: +104.92%
Aug 12, 2025
Maintained: Buy
Price Target: $10
Current: $1.63
Upside: +513.50%
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $23.55
Upside: -15.07%
Aug 1, 2025
Maintained: Buy
Price Target: $36
Current: $7.01
Upside: +413.55%
May 13, 2025
Maintained: Hold
Price Target: n/a
Current: $5.95
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.0497
Upside: n/a
Jan 13, 2025
Maintained: Buy
Price Target: n/a
Current: $232.77
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $4
Current: $10.55
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $1.88
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $20
Current: $67.00
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $70
Current: $1.06
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: n/a
Current: $5.01
Upside: n/a
May 3, 2022
Maintained: Buy
Price Target: n/a
Current: $58.34
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: $25
Current: $135.44
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $36.57
Upside: n/a
Apr 5, 2021
Maintained: Buy
Price Target: $31
Current: $181.34
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $446.83
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $635.45
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $57.27
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $15.88
Upside: n/a
Jan 31, 2018
Maintained: Buy
Price Target: $42
Current: $26.04
Upside: n/a
Dec 18, 2017
Maintained: Hold
Price Target: $34 → $20
Current: $34.19
Upside: n/a
Oct 30, 2017
Maintained: Buy
Price Target: $67
Current: $120.79
Upside: n/a
Oct 13, 2017
Maintained: Hold
Price Target: $95
Current: $227.23
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $10.83
Upside: n/a
Jul 26, 2017
Maintained: Hold
Price Target: $85
Current: $1,131.42
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $13.75
Upside: n/a
Nov 2, 2016
Maintained: Buy
Price Target: $118
Current: $129.16
Upside: n/a
Jun 14, 2016
Maintained: Buy
Price Target: $20
Current: $23.44
Upside: n/a
Jun 14, 2016
Maintained: Sell
Price Target: $8
Current: $3.31
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $7.49
Upside: n/a